Production of recombinant proteins by microbes and higher organisms
- PMID: 19500547
- DOI: 10.1016/j.biotechadv.2009.01.008
Production of recombinant proteins by microbes and higher organisms
Abstract
Large proteins are usually expressed in a eukaryotic system while smaller ones are expressed in prokaryotic systems. For proteins that require glycosylation, mammalian cells, fungi or the baculovirus system is chosen. The least expensive, easiest and quickest expression of proteins can be carried out in Escherichia coli. However, this bacterium cannot express very large proteins. Also, for S-S rich proteins, and proteins that require post-translational modifications, E. coli is not the system of choice. The two most utilized yeasts are Saccharomyces cerevisiae and Pichia pastoris. Yeasts can produce high yields of proteins at low cost, proteins larger than 50 kD can be produced, signal sequences can be removed, and glycosylation can be carried out. The baculoviral system can carry out more complex post-translational modifications of proteins. The most popular system for producing recombinant mammalian glycosylated proteins is that of mammalian cells. Genetically modified animals secrete recombinant proteins in their milk, blood or urine. Similarly, transgenic plants such as Arabidopsis thaliana and others can generate many recombinant proteins.
Similar articles
-
Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.J Mol Recognit. 2005 Mar-Apr;18(2):119-38. doi: 10.1002/jmr.687. J Mol Recognit. 2005. PMID: 15565717 Review.
-
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.Nat Biotechnol. 2004 Nov;22(11):1409-14. doi: 10.1038/nbt1028. Nat Biotechnol. 2004. PMID: 15529166 Review.
-
Pharming and transgenic plants.Biotechnol Annu Rev. 2007;13:115-47. doi: 10.1016/S1387-2656(07)13006-4. Biotechnol Annu Rev. 2007. PMID: 17875476 Review.
-
Moss bioreactors producing improved biopharmaceuticals.Curr Opin Biotechnol. 2007 Oct;18(5):393-8. doi: 10.1016/j.copbio.2007.07.012. Epub 2007 Sep 14. Curr Opin Biotechnol. 2007. PMID: 17869503 Review.
-
Comparison of two expression platforms in respect to protein yield and quality: Pichia pastoris versus Pichia angusta.Protein Expr Purif. 2009 Aug;66(2):165-71. doi: 10.1016/j.pep.2009.03.010. Epub 2009 Apr 7. Protein Expr Purif. 2009. PMID: 19358890
Cited by
-
COVID-19 vaccine platforms: Delivering on a promise?Hum Vaccin Immunother. 2021 Sep 2;17(9):2873-2893. doi: 10.1080/21645515.2021.1911204. Epub 2021 May 25. Hum Vaccin Immunother. 2021. PMID: 34033528 Free PMC article. Review.
-
Biochemical approaches to C4 photosynthesis evolution studies: the case of malic enzymes decarboxylases.Photosynth Res. 2013 Nov;117(1-3):177-87. doi: 10.1007/s11120-013-9879-1. Epub 2013 Jul 7. Photosynth Res. 2013. PMID: 23832612 Review.
-
Comparative evaluation of heterologous production systems for recombinant pulmonary surfactant protein D.Front Immunol. 2014 Dec 8;5:623. doi: 10.3389/fimmu.2014.00623. eCollection 2014. Front Immunol. 2014. PMID: 25538707 Free PMC article. Review.
-
Expression of synthetic human tropoelastin (hTE) protein in Nicotiana tabacum.GM Crops Food. 2015;6(1):54-62. doi: 10.1080/21645698.2015.1026524. GM Crops Food. 2015. PMID: 25984768 Free PMC article.
-
Strategic optimization of conditions for the solubilization of GST-tagged amphipathic helix-containing ciliary proteins overexpressed as inclusion bodies in E. coli.Microb Cell Fact. 2022 Dec 12;21(1):258. doi: 10.1186/s12934-022-01979-y. Microb Cell Fact. 2022. PMID: 36510188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources